360 High-Risk Vulnerability Immunization Tool V2.0 vs Xcitium Endpoint Detection and Response (EDR): Side-by-Side Comparison (2026)

Short answer

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Mid-market and enterprise security teams that need fast incident response without operational friction should evaluate Xcitium Endpoint Detection and Response. The platform's strength lies in threat analysis and containment; it covers NIST DE.AE and RS.MI solidly, meaning you get good signal on what's happening and the ability to act before lateral movement spreads. The caveat: this tool prioritizes detection and response over forensic depth, so organizations building mature incident investigation workflows or compliance-heavy post-breach documentation may find the evidence collection and reporting thinner than competitors.